| dc.contributor.author |
Kirmani N |
en_US |
| dc.contributor.author |
Haq T |
en_US |
| dc.date.accessioned |
2017-01-30T08:16:12Z |
|
| dc.date.available |
2017-01-30T08:16:12Z |
|
| dc.identifier.uri |
http://hdl.handle.net/123456789/175806 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/1/569 |
|
| dc.description.abstract |
The broad objective of this case is to bring out the cost and benefits of multinational companies and foreign direct investment. This would include the global effects of multinationals, their benefits to the home country, home host company conflicts and views of the host country. |
en_US |
| dc.publisher |
NO |
en_US |
| dc.subject |
Pharmaceuticals |
|
| dc.subject.classification |
Business,Government,International Economy |
en_US |
| dc.subject.other |
Cost/benefit analysis |
en_US |
| dc.subject.other |
foreign investment |
en_US |
| dc.subject.other |
multinational |
en_US |
| dc.title |
PHARMACEUTICAL INDUSTRY IN PAKISTAN: ROLE OF GLAXO- A MULTINATIONALCOMPANY |
en_US |
| dc.type |
16-158-88-1 |
en_US |
| dc.location |
case research centre |
en_US |